Furthermore, the binding of USP17 to TRAF2/TRAF3 activates the NF-κB signaling pathway [116], which, in addition to regulating the inflammatory response, is involved in the induction of EMT and the acquisition of stem-like properties in NSCLC cells [117]. Here, NFKB1 is linked to non-small cell lung carcinoma.